2361 — Sinohealth Technology Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeSmall CapHigh Flyer

Market Cap
HK$2.27bn
Enterprise Value
HK$1.56bn
Revenue
CNY419.09m

Annual income statement for Sinohealth Technology Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	324	357	396	404	419
Cost of Revenue
Gross Profit	193	159	223	233	249
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	228	302	285	283	313
Operating Profit	96.5	54.9	111	121	106
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	95.5	54.5	111	120	106
Provision for Income Taxes
Net Income After Taxes	72	54.2	101	112	94.5
Minority Interest
Net Income Before Extraordinary Items
Net Income	78.8	55.8	102	111	93.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	78.8	55.8	102	111	93.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.208	0.135	0.239	0.27	0.223
Dividends per Share
Special Dividends per Share